Apellis Pharmaceuticals's Earnings Outlook

Apellis Pharmaceuticals APLS is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Apellis Pharmaceuticals will report an earnings per share (EPS) of $-0.34.

The announcement from Apellis Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Historical Earnings Performance

Last quarter the company beat EPS by $0.11, which was followed by a 0.0% drop in the share price the next day.

Here's a look at Apellis Pharmaceuticals's past performance and the resulting price change:

Performance of Apellis Pharmaceuticals Shares

Shares of Apellis Pharmaceuticals were trading at $19.98 as of May 05. Over the last 52-week period, shares are down 53.25%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Apellis Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.